Status:
COMPLETED
Vivity Outcomes in Patients With Early Stage Glaucoma
Lead Sponsor:
Vance Thompson Vision
Conditions:
Glaucoma
Cataract
Eligibility:
All Genders
45+ years
Brief Summary
The goal of the study is to determine the visual outcomes in patients with mild, pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular L...
Eligibility Criteria
Inclusion
- Patients at least age 45 years of age undergoing uncomplicated cataract surgery with optional concomitant minimally invasive glaucoma surgery (MIGS)
- Subjects with documented diagnosis of pre-perimetric glaucoma
- Calculated lens power within Vivity/Vivity toric range
- Willing and able to comprehend informed consent and complete 4-6 month post-op visit
- Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
Exclusion
- Ocular comorbidity, other than pre-perimetric glaucoma, that could reduce the potential postoperative BCDVA
- Previous ocular surgery including refractive surgery
- Subjects who are pregnant or plan to become pregnant during the course of the study.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04670575
Start Date
January 1 2021
End Date
November 30 2022
Last Update
May 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vance Thompson Vision
Sioux Falls, South Dakota, United States, 57108